Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corneal tomography detection of elevated ectasia risk in atopic dermatitis patients with no prior ophthalmologic diagnosis.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia·2026

Same author

Corneal sub-basal nerve fiber plexus tortuosity in eyes with ectasia susceptibility and keratoconus: A cross-sectional in vivo confocal microscopy study.

The ocular surface·2026

Same author

Influence of Topical Medication on Corneal Biomechanics in Primary Open-Angle Glaucoma.

Cornea·2026

Same author

The corneal thickness profile in different forms of glaucoma.

Scientific reports·2025

Same author

New keratoconus grading system based on OCT: threshold adjustment for SS-OCT.

Journal of cataract and refractive surgery·2025

Same author

Differentiation Between Pellucid-Like Keratoconus and Pellucid Marginal Degeneration Using Swept-Source Optical Coherence Tomography.

Cornea·2025

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins affect ocular microcirculation in patients with hypercholesterolaemia.

Naim Terai¹, Eberhard Spoerl, Sabine Fischer

¹Department of Ophthalmology, University Hospital Dresden, Dresden, Germany. naim.terai@uniklinikum-dresden.de

Acta Ophthalmologica

|April 5, 2011

Summary

Statin therapy significantly improved retinal microcirculation, increasing vasodilatation in arterioles and venules within four weeks for hypercholesterolemia patients. These findings suggest statins have beneficial pleiotropic effects on ocular blood vessels.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

Ophthalmology
Cardiovascular Research
Pharmacology

Background:

Hypercholesterolemia is a major risk factor for cardiovascular and ocular diseases.
Statins are primarily used to lower cholesterol but may have other beneficial effects.
Ocular microcirculation plays a crucial role in maintaining retinal health.

Purpose of the Study:

To evaluate the impact of statin treatment on the ocular microcirculation in patients with hypercholesterolemia.
To assess changes in retinal vessel diameter and vasodilation response after statin therapy.

Main Methods:

Ten patients with hypercholesterolemia underwent retinal vessel analysis (RVA) before and after four weeks of statin therapy.
Retinal arteriole and venule diameters were measured at baseline and during induced vasodilation.
Lipid profiles (cholesterol, HDL, LDL, triglycerides) were correlated with vascular changes.

Main Results:

Statin therapy significantly increased the baseline diameter of retinal arterioles and venules.
A significant enhancement in flicker-induced vasodilation of retinal arterioles and venules was observed post-statin treatment.
Improvements in ocular microcirculation correlated with lipid-lowering effects of statins.

Conclusions:

Statin therapy demonstrates significant pleiotropic effects on the retinal microcirculation.
The observed vasodilatation suggests an improvement in endothelial function, likely mediated by nitric oxide.
These findings highlight potential benefits of statins beyond lipid-lowering for ocular health.